{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:06:04Z","timestamp":1793127964650,"version":"4.5.0"},"reference-count":78,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.8279","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T15:32:17Z","timestamp":1592580737000},"page":"e208279","source":"Crossref","is-referenced-by-count":258,"title":["Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders"],"prefix":"10.1001","volume":"3","author":[{"given":"Lara A.","family":"Ray","sequence":"first","affiliation":[{"name":"Department of Psychology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Meredith","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kiluk","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Walthers","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Magill","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"issue":"2","key":"zoi200356r1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review.","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi200356r2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review.","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"issue":"17","key":"zoi200356r3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"zoi200356r4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The role of behavioral interventions in buprenorphine maintenance treatment: a review.","volume":"174","author":"Carroll","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"18","key":"zoi200356r6","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/jama.2014.3629","article-title":"Bringing patient-centered care to patients with alcohol use disorders.","volume":"311","author":"Bradley","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"zoi200356r7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"zoi200356r9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1017\/S1461145704004997","article-title":"Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.","volume":"8","author":"Srisurapanont","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"18","key":"zoi200356r10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"zoi200356r11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/add.2013.108.issue-2","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"5","key":"zoi200356r12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence.","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"issue":"12","key":"zoi200356r13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1037\/ccp0000447","article-title":"A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition.","volume":"87","author":"Magill","year":"2019","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"zoi200356r14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1037\/0022-006X.67.4.563","article-title":"Efficacy of relapse prevention: a meta-analytic review.","volume":"67","author":"Irvin","year":"1999","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"zoi200356r15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.15288\/jsad.2009.70.516","article-title":"Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.","volume":"70","author":"Magill","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"issue":"2","key":"zoi200356r16","first-page":"78","article-title":"Cognitive-behavioral coping-skills therapy for alcohol dependence: current status and future directions.","volume":"23","author":"Longabaugh","year":"1999","journal-title":"Alcohol Res Health"},{"issue":"5","key":"zoi200356r17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use.","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"issue":"2","key":"zoi200356r18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0306-4603(96)00038-X","article-title":"Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes.","volume":"22","author":"Carroll","year":"1997","journal-title":"Addict Behav"},{"issue":"10","key":"zoi200356r19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/archpsyc.1997.01830220041007","article-title":"Manual-guided psychosocial treatment: a new virtual requirement for pharmacotherapy trials?","volume":"54","author":"Carroll","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"zoi200356r21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1037\/adb0000311","article-title":"Cognitive behavioral interventions for alcohol and drug use disorders: through the stage model and back again.","volume":"31","author":"Carroll","year":"2017","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"zoi200356r23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/adb0000277","article-title":"Follow-up treatment effects of contingency management and motivational interviewing on substance use: a meta-analysis.","volume":"31","author":"Sayegh","year":"2017","journal-title":"Psychol Addict Behav"},{"issue":"12","key":"zoi200356r24","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1111\/add.v114.12","article-title":"Pharmacotherapy for methamphetamine\/amphetamine use disorder: a systematic review and meta-analysis.","volume":"114","author":"Chan","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"zoi200356r25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1037\/a0013171","article-title":"Distinctions without a difference: direct comparisons of psychotherapies for alcohol use disorders.","volume":"22","author":"Imel","year":"2008","journal-title":"Psychol Addict Behav"},{"issue":"6","key":"zoi200356r27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"zoi200356r28","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"zoi200356r32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer.","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"issue":"4","key":"zoi200356r34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","article-title":"Fixed-and random-effects models in meta-analysis.","volume":"3","author":"Hedges","year":"1998","journal-title":"Psychol Methods"},{"issue":"1","key":"zoi200356r35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JCP.0b013e31827bfff4","article-title":"A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.","volume":"33","author":"D\u00fcrsteler-MacFarland","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"zoi200356r36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127598","article-title":"Efficacy of cognitive behavioral therapy on opiate use and retention in methadone maintenance treatment in China: a randomised trial.","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"zoi200356r37","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4088\/JCP.v65n1017","article-title":"Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.","volume":"65","author":"Wetzel","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi200356r38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.","volume":"21","author":"Hein\u00e4l\u00e4","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"zoi200356r39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-009-1615-3","article-title":"Extended naltrexone and broad spectrum treatment or motivational enhancement therapy.","volume":"206","author":"Longabaugh","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"zoi200356r40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1037\/a0028615","article-title":"A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men.","volume":"80","author":"Morgenstern","year":"2012","journal-title":"J Consult Clin Psychol"},{"issue":"9","key":"zoi200356r41","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archinte.165.9.986","article-title":"Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis.","volume":"165","author":"Bertholet","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi200356r42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000086397","article-title":"Group psychotherapy for opiate addicts in methadone maintenance treatment: a controlled trial.","volume":"11","author":"Scherbaum","year":"2005","journal-title":"Eur Addict Res"},{"issue":"7","key":"zoi200356r43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"zoi200356r44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1994.03950030013002","article-title":"Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.","volume":"51","author":"Carroll","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"zoi200356r45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"issue":"11","key":"zoi200356r46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study.","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"14","key":"zoi200356r47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/archinte.163.14.1695","article-title":"Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.","volume":"163","author":"O\u2019Malley","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi200356r48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","article-title":"Naltrexone and relapse prevention treatment for cocaine-dependent patients.","volume":"26","author":"Schmitz","year":"2001","journal-title":"Addict Behav"},{"issue":"4","key":"zoi200356r49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10550490490480982","article-title":"Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.","volume":"13","author":"Schmitz","year":"2004","journal-title":"Am J Addict"},{"issue":"4","key":"zoi200356r50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.jcp.0000172071.81258.04","article-title":"Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.","volume":"25","author":"Anton","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"zoi200356r51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.15288\/jsad.2007.68.238","article-title":"Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?","volume":"68","author":"Davidson","year":"2007","journal-title":"J Stud Alcohol Drugs"},{"issue":"4","key":"zoi200356r52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/alcalc\/37.4.375","article-title":"Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?","volume":"37","author":"De Wildt","year":"2002","journal-title":"Alcohol Alcohol"},{"issue":"10","key":"zoi200356r53","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/add.12266","article-title":"Comparison of behavioral treatment conditions in buprenorphine maintenance.","volume":"108","author":"Ling","year":"2013","journal-title":"Addiction"},{"issue":"7","key":"zoi200356r54","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"zoi200356r55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/02791072.2014.960110","article-title":"A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.","volume":"46","author":"Otto","year":"2014","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"zoi200356r56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jsat.2007.05.011","article-title":"Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.","volume":"34","author":"Pettinati","year":"2008","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"zoi200356r57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archpsyc.59.9.817","article-title":"A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence.","volume":"59","author":"Rawson","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"1-3","key":"zoi200356r58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi200356r59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2004.08.003","article-title":"A randomized control trial of group counseling in a naltrexone treatment program.","volume":"27","author":"Tucker","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"zoi200356r60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ajad.12292","article-title":"The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.","volume":"24","author":"Saunders","year":"2015","journal-title":"Am J Addict"},{"issue":"4","key":"zoi200356r61","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/acer.12317","article-title":"The place of additional individual psychotherapy in the treatment of alcoholism: a randomized controlled study in nonresponders to anticraving medication-results of the PREDICT study.","volume":"38","author":"Berner","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi200356r62","doi-asserted-by":"crossref","first-page":"74.e11","DOI":"10.1016\/j.amjmed.2012.07.005","article-title":"A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.","volume":"126","author":"Fiellin","year":"2013","journal-title":"Am J Med"},{"issue":"2","key":"zoi200356r64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00131746-200603000-00003","article-title":"The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.","volume":"12","author":"Starosta","year":"2006","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"zoi200356r65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1037\/0893-164X.17.1.73","article-title":"Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.","volume":"17","author":"Epstein","year":"2003","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"zoi200356r66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1049731509347850","article-title":"A meta-analysis of motivational interviewing: twenty-five years of empirical studies.","volume":"20","author":"Lundahl","year":"2010","journal-title":"Res Soc Work Pract"},{"issue":"1","key":"zoi200356r67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0376-8716(02)00014-5","article-title":"The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies.","volume":"67","author":"Prendergast","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi200356r68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence.","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"6","key":"zoi200356r69","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/alcalc\/36.6.544","article-title":"Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials.","volume":"36","author":"Streeton","year":"2001","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"zoi200356r70","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1176\/appi.ajp.162.8.1452","article-title":"Behavioral therapies for drug abuse.","volume":"162","author":"Carroll","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi200356r71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.","volume":"45","author":"Ray","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"zoi200356r72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders.","volume":"165","author":"Dutra","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"11","key":"zoi200356r73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11920-013-0415-y","article-title":"Pharmacotherapy for stimulant-related disorders.","volume":"15","author":"Haile","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"7","key":"zoi200356r74","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1530-0277.2003.tb02873.x","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi200356r75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v19n01_06","article-title":"Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.","volume":"19","author":"Pettinati","year":"2000","journal-title":"J Addict Dis"},{"key":"zoi200356r76","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1046\/j.1360-0443.95.11s3.9.x","article-title":"Meta-analyses in alcohol and other drug abuse treatment research.","volume":"95","author":"Wilson","year":"2000","journal-title":"Addiction"},{"issue":"5","key":"zoi200356r77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1037\/0278-6133.23.5.443","article-title":"Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.","volume":"23","author":"Bellg","year":"2004","journal-title":"Health Psychol"},{"issue":"1","key":"zoi200356r78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/add.14289","article-title":"What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?","volume":"114","author":"Kiluk","year":"2019","journal-title":"Addiction"},{"key":"zoi200356r5","volume-title":"Principles of Drug Addiction Treatment: A Research Based Guide","author":"National Institute on Drug Abuse","year":"2007"},{"key":"zoi200356r20","author":"Wallace","year":"2012"},{"key":"zoi200356r22","volume-title":"Handbook of Alcoholism Treatment Approaches: Effective Alternatives.","author":"Miller","year":"2003"},{"key":"zoi200356r26","doi-asserted-by":"crossref","DOI":"10.4324\/9780203582015","volume-title":"The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work","author":"Wampold","year":"2015"},{"key":"zoi200356r29","doi-asserted-by":"crossref","DOI":"10.7758\/9781610448864","volume-title":"The Handbook of Research Synthesis and Meta-analysis","author":"Cooper","year":"2019"},{"key":"zoi200356r30","volume-title":"Statistical Methods for Meta-analysis","author":"Hedges","year":"2014"},{"key":"zoi200356r31","volume-title":"Practical Meta-analysis","author":"Lipsey","year":"2001"},{"key":"zoi200356r33","author":"Borenstein","year":"2015"},{"key":"zoi200356r63","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi200356r8","unstructured":"Substance Abuse and Mental Health Services Administration. National survey on drug use and health 2014. Published 2014. Accessed December 2019. https:\/\/datafiles.samhsa.gov\/study\/national-survey-drug-use-and-health-nsduh-2014-nid13618"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2767358\/ray_2020_oi_200356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T15:33:03Z","timestamp":1592580783000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2767358"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.8279","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}